ATTN LogoMenu
8KTier 5
Articles

FibroBiologics, Inc. 8K

0001193125-26-299290

View on SEC EDGAR

FibroBiologics, Inc. appointed retired NASA astronaut and microbiologist Kathleen "Kate" Rubins, Ph.D. to its Board of Directors.

FibroBiologics, Inc. announced that Kathleen "Kate" Rubins, Ph.D.—a microbiologist, genomics scientist, retired NASA astronaut, and founding director of the University of Pittsburgh’s Trivedi Institute for Space and Global Biomedicine—has been appointed to its Board of Directors, expanding her role with the company beyond her prior service on its Scientific Advisory Board to help guide its fibroblast-based cell therapy pipeline and long-term scientific strategy.

Filing Facts

CIK
1958777
Ticker
-
Form
8K
Source Type
sec
Accession
0001193125-26-299290
Alert Tier
5
FibroBiologics, Inc. 8K | ATTN